His research aims to provide valuable insights into how space conditions may affect the efficacy and safety of drugs, contributing to the development of guidelines for future space missions. He has made excellent progress in his studies and has great presentation skills. In February, Dr. Amir Makolli was named the Best First-Year Ph.D. Student at the Centre for Translational Medicine.
After completing his studies in pharmacy, Dr. Makolli sought the CTM’s Ph.D. program. The Centre caught his attention through informative videos highlighting its commitment to bridging the gap between science and patient care. This resonated with him as it emphasized the importance of grounding research in real-world applications. “The focus of translational medicine on connecting scientific advancements with patient outcomes aligns with my belief in the fundamental link between research and healthcare. The program’s holistic approach, starting from the patients’ perspective and circling back to the application, drew me in and influenced my decision to pursue this unique Ph.D. training.”
Dr. Makolli’s Ph.D. work involves investigating the impact of space travel on humans, specifically focusing on pharmacological aspects. His research aims to provide valuable insights into how space conditions may affect the efficacy and safety of drugs, contributing to the development of guidelines for future space missions. Initially, the idea of space research seemed futuristic and unrealistic, but as he delved deeper into this subject, he became captivated by its extraordinary nature. “Space research encourages critical thinking beyond conventional boundaries and provides an opportunity to explore the impact of space travel on humans, including the pharmacology of drugs. The relevancy of this research became apparent, considering the ongoing advancements in space exploration.” For him, space research offers a chance to think outside the box, both metaphorically and literally.
“Since my research work is facilitated by the supportive environment provided by CTM and Semmelweis University, I can balance it with my pharmacology work. The guidance from our SMS, clinical supervisors, group meeting colleagues, coordinators, and Peter Hegyi himself has been instrumental. This collaborative approach and effective time management have enabled us to implement a learning-by-doing strategy, contributing to our success within this renowned institution.”
(Szabó Emese)